Neuroendocrine Prostate Cancer: Report of a Prostate Cancer Subtype with Atypical Metastatic Imaging and Clinical Findings

• DOI: 10.3941/jrcr.5324
• Publication Date: 2024-08-06T00:08:01Z
• Authors: Bryan Nixon; Pritish Aher

Prostate cancer is the leading cause of malignancy in males, and vast majority cases consist androgen-sensitive acinar adenocarcinoma. Multiple relatively rare subtypes prostate have been described, including a neuroendocrine cancer, which can arise response to androgen-deprivation treatment setting existing prostatic Neuroendocrine an uncommon subtype with highly aggressive course lack distinguishing features on conventional imaging. We present case developed into atypical metastatic imaging appearance describe characteristics that may suggest histopathologic change from original malignancy.